Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8071 to 8085 of 8216 results

  1. Durvalumab with transarterial chemoembolisation for treating incurable locally advanced hepatocellular carcinoma [ID5124]

    Awaiting development [GID-TA11019] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease ID6343

    In development [GID-TA11379] Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Fertility problems: assessment and treatment

    In development [GID-NG10263] Expected publication date: 29 May 2025

    NICE guideline
    In development

  4. Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia

      Status ...

    Medical technologies guidance
    Topic selection

  5. CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease (MT434

      Status ...

    Diagnostics guidance
    Topic selection

  6. Insertion of a Catheter based intravascular microaxial blood pump for acute heart failure

    Awaiting development [GID-IPG10404] Expected publication date: TBC

    Interventional procedures guidance
    Awaiting development

  7. In-situ Normothermic Regional Perfusion system for DCD donors

    Awaiting development [GID-IPG10405] Expected publication date: TBC

    Interventional procedures guidance
    Awaiting development

  8. Insertion of neo-chordae into the beating heart for mitral regurgitation

    In development [GID-IPG10216] Expected publication date: TBC

    Interventional procedures guidance
    In development

  9. Xevinapant with platinum-based chemotherapy and radiotherapy for untreated locally advanced squamous cell head and neck cancer [ID6199]

    Awaiting development [GID-TA11166] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Olaparib with cediranib for treating platinum-resistant recurrent ovarian cancer after 1 or 2 therapies [ID4065]

    In development [GID-TA11033] Expected publication date: TBC

    Technology appraisal guidance
    In development

  11. Troriluzole for spinocerebellar ataxia TS ID 12013

    Awaiting development [GID-TA11549] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Pembrolizumab with chemotherapy for neoadjuvant and adjuvant treatment of cisplatin-eligible muscle-invasive bladder cancer [ID6219]

    Awaiting development [GID-TA11137] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer ID5110

    In development [GID-TA11023] Expected publication date: TBC

    Technology appraisal guidance
    In development

  14. IgPro20 for treating dermatomyositis TS ID 12014

    Awaiting development [GID-TA11550] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)

    Discontinued [GID-MT517]

    Medical technologies guidance
    Discontinued